Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats (Q83000068)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Combined amylin-leptin treatment lowers blood pressure and adiposity in lean and obese rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

R Seth

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

W D Knight

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J M Overton

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

21 December 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Obesity

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1183-1192

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21179001%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ijo.2010.262

18 January 2020

exact match

0 references

cites work

Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

It takes two to tango: combined amylin/leptin agonism as a potential approach to obesity drug development

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Insights into amylin-leptin synergy

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Central nervous system control of food intake

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Modulation of blood pressure by central melanocortinergic pathways

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Cardiovascular side effects of antiobesity drugs: a yellow flag in the race to safe pharmacotherapy for obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Intracellular mechanisms involved in leptin regulation of sympathetic outflow

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Hypothalamic arcuate nucleus mediates the sympathetic and arterial pressure responses to leptin.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Short-term physiological hyperleptinemia decreases arterial blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Central leptin infusion attenuates the cardiovascular and metabolic effects of fasting in rats.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Cardiovascular effects

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Behavioral impairments of the aging rat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Daily cycles in body temperature, metabolic rate, and substrate utilization in pigeons: influence of amount and timing of food consumption.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Concurrent reductions in blood pressure and metabolic rate during fasting in the unrestrained SHR.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Dietary fat, lipogenesis and energy balance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

The reconstruction of Kleiber's law at the organ-tissue level

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

https://api.crossref.org/works/10.1038%2FIJO.2010.262

1 reference

7 January 2021

The 3/4 mass exponent for energy metabolism is not a statistical artifact.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

https://api.crossref.org/works/10.1038%2FIJO.2010.262

1 reference

7 January 2021

Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Physiological response to long-term peripheral and central leptin infusion in lean and obese mice

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin receptor action and mechanisms of leptin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Hypothalamic leptin resistance is associated with impaired leptin signal transduction in aged obese rats

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Mechanisms of amylin/leptin synergy in rodent models

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Differential effects of amylin and salmon calcitonin on neuropeptide gene expression in the lateral hypothalamic area and the arcuate nucleus of the rat.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Pancreatic amylin as a centrally acting satiating hormone

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

The role of SOCS-3 in leptin signaling and leptin resistance

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Ageing increases SOCS-3 expression in rat hypothalamus: effects of food restriction

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Nutritional regulation of hypothalamic leptin receptor gene expression is defective in diet-induced obesity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Inhibition of NO synthesis enhances chronic cardiovascular and renal actions of leptin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Melanocortin-4 receptor mediates chronic cardiovascular and metabolic actions of leptin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Role of PI3K and PKB/Akt in acute natriuretic and NO-mimetic effects of leptin

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

The Inhibitory Effect of Leptin on Angiotensin II-Induced Vasoconstriction in Vascular Smooth Muscle Cells Is Mediated via a Nitric Oxide-Dependent Mechanism

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Chronic cardiovascular and renal actions of leptin: role of adrenergic activity

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Role of hypothalamic melanocortin 3/4-receptors in mediating chronic cardiovascular, renal, and metabolic actions of leptin.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin and vascular function: Friend or foe?

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021

Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.

1 reference

https://api.crossref.org/works/10.1038%2FIJO.2010.262

7 January 2021